Retina
nAMD and DME: Unveiling New Frontiers in Management
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
VIDEO: Duravyu for wet AMD shows positive 12-month outcomes vs. aflibercept
CHICAGO — In this Healio Video Perspective from the AAO meeting, Ramiro Ribeiro, MD, PhD, of EyePoint Pharmaceuticals, shares phase 2 data investigating Duravyu for wet age-related macular degeneration treatment vs. aflibercept.
Taming the Tide: Management of Persistent Retinal Fluid in nAMD and DME
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Report details feasibility of whole eye transplant
A patient who underwent a combined whole eye and face transplant maintained globe and retinal perfusion as well as retinal response to light with no instance of acute rejection, according to a report in JAMA.
Anti-VEGF Treatment Strategy for nAMD and DME Matters for Best Outcomes! Evaluating the Evidence
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
VIDEO: Greater improvements seen with dual pathway therapy in retinal diseases
NEW YORK — In this Healio Video Perspective from OSN New York Retina, Rishi P. Singh, MD, FASRS, discusses biomarkers for angiopoietin-2 and VEGF inhibition in wet age-related macular degeneration and diabetic macular edema.
VIDEO: EyePoint shares updates on Duravyu for wet AMD, DME
CHICAGO — In this Healio Video Perspective from the AAO meeting, Jay S. Duker, MD, president and CEO of EyePoint Pharmaceuticals, shares an update on Duravyu for wet age-related macular degeneration.
VIDEO: ANXV shows early positive results in treatment of retinal vein occlusion
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Anders Haegerstrand, MD, PhD, and Anna Frostegård, MD, PhD, of Annexin Pharmaceuticals discuss a phase 2a trial of ANXV for the treatment of retinal vein occlusion.
VIDEO: Treatments available for patients with vitreous floaters
BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Paulo-Eduardo Stanga, MD, speaks in favor of treating vitreous floaters and opacities.
VIDEO: Technology needed to measure impact of geographic atrophy treatment
NEW YORK — In this Healio Video Perspective from OSN New York Retina, Lejla Vajzovic, MD, FASRS, of Duke Eye Center in Durham, North Carolina, discusses the adoption of therapies for the treatment of geographic atrophy.